Gilead registers two Phase 2 trials: PBC combo study and weekly oral HIV regimenSep 25Weekly roundup, 2 itemsGilead SciencesGS-3242
Merck posts Q2 loss on Terns charge, raises full-year sales outlookAug 4Quarterly updateMerck & Co., Inc.
Gilead reports Q2 2026 results with three FDA approvals, three positive Phase 3 readoutsAug 4Quarterly updateGilead Sciences
Gilead registers Phase 2/3 HIV combo trial and Phase 1 oncology study for GS-1206Jul 16Weekly roundup, 2 itemsGilead SciencesGS-1206
Gilead registers two Phase 3 trials of lenacapavir long-acting regimen with TAB and ZABJul 6Weekly roundup, 2 itemsGilead Scienceslenacapavir
Sign inSign in